NeuroMetrix, Inc. (NURO) Financials
Stock symbol NURO is outdated, potentially delisted? Maybe it is available on other exchange?
NURO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2024 | 17.2 million | 1.2 million |
| June 30, 2024 | 18.9 million | 1.6 million |
| March 31, 2024 | 20.7 million | 1.9 million |
| Dec. 31, 2023 | 21.4 million | 1.3 million |
NURO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2024 | -1.8 million | 203870 |
| June 30, 2024 | -1.4 million | 176148 |
| March 31, 2024 | -2.1 million | 216164 |
| Dec. 31, 2023 | -1.5 million | 180131 |
NURO Net Income
No data available :(
NURO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2024 | 14.8 million | - | - |
| June 30, 2024 | 16.4 million | 28210 | 176601 |
| March 31, 2024 | 17.6 million | 60946 | 209337 |
| Dec. 31, 2023 | 18.0 million | 92485 | 240876 |
NURO Shares Outstanding
NURO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2024 | 3 | 299739 | 1.8 million | 441171 |
| June 30, 2024 | 3 | 266932 | 2.1 million | 435014 |
| March 31, 2024 | - | 943552 | 2.8 million | 1.1 million |
| Dec. 31, 2023 | 45366 | 732372 | 2.0 million | 860635 |
NURO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2024 | 587314 | 275357 |
| June 30, 2024 | 769148 | 277229 |
| March 31, 2024 | 1.1 million | 576539 |
| Dec. 31, 2023 | 1.3 million | 469772 |
NURO
Price: $4.58
52 week price:
Earnings Per Share: -3.96 USD
P/E Ratio: -1.16
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 39500
Ebitda: -2.8 millionMarket Capitalization: 9.4 million